Biocon considers merger or IPO for Biocon Biologics
pre-market1 source ↓written by the desknot a recommendation
- merger of Biocon
- $4.5 billion
Biocon Ltd. is evaluating a $4.5 billion merger of Biocon Biologics with itself, while also considering an IPO. Kiran Mazumdar-Shaw confirmed that discussions with minority shareholders are ongoing, with options for a share swap or cash. Morgan Stanley has been appointed to guide the decision-making process. 📈
This move could impact investor sentiment and valuation strategies in the biosimilars sector.
Not investment advice. For informational purposes only.